The Protective Effect of Thymosin Alpha 1 (Zadaxin) for Small Hepatocellular Carcinoma from Recurrence/Metastasis Following Radical Resection: A Randomised Controlled Prospective Study.

Trial Profile

The Protective Effect of Thymosin Alpha 1 (Zadaxin) for Small Hepatocellular Carcinoma from Recurrence/Metastasis Following Radical Resection: A Randomised Controlled Prospective Study.

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Jun 2010

At a glance

  • Drugs Thymalfasin (Primary)
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top